In the BioHarmony Drug Report Database
Clemastine
Tavist (clemastine) is a small molecule pharmaceutical. Clemastine was first approved as Tavist on 1982-01-01. It is used to treat allergic rhinitis perennial, angioedema, and urticaria in the USA. The pharmaceutical is active against histamine H1 receptor. In addition, it is known to target P2X purinoceptor 7.
Trade Name
|
Tavist |
|---|---|
Common Name
|
clemastine |
ChEMBL ID
|
CHEMBL1626 |
Indication
|
allergic rhinitis perennial, angioedema, urticaria |
Drug Class
|
Antihistaminics (histamine-H1 receptor antagonists) |
Image (chem structure or protein)